When PD-L1 on tumor cells binds to PD-1 on T cells, it hinders T cell proliferation and promotes cell death, ultimately suppressing the body’s ability to mount an effective anti-tumor immune response (Zhou et al., 2023). Here, CD274 is linked to neoplasm.